本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aclaris Therapeutics

5.45
-0.1950-3.46%
成交量:41.87萬
成交額:229.15萬
市值:8.01億
市盈率:-9.29
高:5.62
開:5.62
低:5.41
收:5.64
52周最高:6.60
52周最低:1.74
股本:1.47億
流通股本:1.10億
量比:0.30
換手率:0.38%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
淨資產收益率:-59.10%
總資產收益率:-28.98%
市淨率:6.43
市盈率(LYR):-10.27

資料載入中...

2020/06/04

重要事件披露

8-K - Current report
2020/05/27

重要事件披露

8-K - Current report
2020/05/15

重要事件披露

8-K - Current report
2020/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

8-K - Current report
2020/05/07

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/04/23

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

重要事件披露

Current report, items 1.01, 2.03, 3.02, 7.01, and 9.01
2020/03/13

重要事件披露

Current report, items 1.01 and 9.01
2020/03/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/06

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/25

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/25

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals